TY - JOUR T1 - Comorbidities and rheumatological diseases at the time of COVID-19. Response to: ‘Rheumatic diseases in intensive care unit patients with COVID-19’ by Moiseev <em>et al</em> JF - Annals of the Rheumatic Diseases JO - Ann Rheum Dis SP - e17 LP - e17 DO - 10.1136/annrheumdis-2020-217800 VL - 80 IS - 2 AU - Sara Monti AU - Carlomaurizio Montecucco Y1 - 2021/02/01 UR - http://ard.bmj.com/content/80/2/e17.abstract N2 - We thank Dr Moiseev et al 1 for their comment on our previous paper on the clinical course of severe acute respiratory syndrome Coronavirus-2 (SARS-CoV-2) disease 2019 (COVID-19) in patients treated with biologic and targeted synthetic disease-modifying anti-rheumatic drugs.2 The authors assessed the outcome of patients with inflammatory rheumatic diseases among patients admitted to the intensive care unit (ICU) and reported findings in line with our cohort of outpatients.2 Admission to the ICU due … ER -